EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer
Authors:
- 1 August 2017
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1868 (1) , 199-211
Abstract
No abstract availableKeywords
Funding Information
- National Science Council of Taiwan (102-2320-B-006-010-MY3, 105-2320-B-006-029-MY3)
This publication has 135 references indexed in Scilit:
- Positron Emission Tomography Imaging of Endometrial Cancer Using Engineered Anti-EMP2 Antibody FragmentsMolecular Imaging and Biology, 2012
- Loss of epithelial membrane protein-2 expression confers an independent prognosticator in nasopharyngeal carcinoma: a cohort studyBMJ Open, 2012
- DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expressionNeuro-Oncology, 2011
- Epithelial membrane protein‐2 expression is an early predictor of endometrial cancer developmentCancer, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCRJournal of Neuro-Oncology, 2008
- Tumor Suppressor FUS1 Signaling PathwayJournal of Thoracic Oncology, 2008
- Gene expression profiling elucidates a specific role for RARγ in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cellsBiochemical Pharmacology, 2008
- Protein kinase CK2 – A key suppressor of apoptosisAdvances in Enzyme Regulation, 2008
- Protein kinase CK2 in mammary gland tumorigenesisOncogene, 2001